NovoCure LimitedNVCRNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+7.8%
5Y CAGR+12.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+7.8%/yr
vs +26.3%/yr prior
5Y CAGR
+12.4%/yr
Recent deceleration
Acceleration
-18.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $642.27M | +0.6% |
| 2024 | $638.53M | +3.9% |
| 2023 | $614.67M | +19.9% |
| 2022 | $512.50M | +10.3% |
| 2021 | $464.49M | +29.9% |
| 2020 | $357.46M | +35.6% |
| 2019 | $263.63M | +30.7% |
| 2018 | $201.69M | +25.5% |
| 2017 | $160.75M | +5.8% |
| 2016 | $151.92M | - |